{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:03:08Z","timestamp":1775714588415,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Korean Society of Interventional Cardiology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11239-020-02240-2","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T12:03:59Z","timestamp":1598529839000},"page":"454-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0403-3726","authenticated-orcid":false,"given":"Young-Hoon","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bliden","family":"Kevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hwa","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Gyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Sin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwhi","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"2240_CR1","first-page":"e139","volume":"141","author":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2020) Heart disease and stroke statistics-2020 update: a report from the american heart association. Circulation 141:e139\u2013e596","journal-title":"Circulation"},{"key":"2240_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4065\/mcp.2011.0010","volume":"86","author":"TA Meadows","year":"2011","unstructured":"Meadows TA, Bhatt DL, Cannon CP, Gersh BJ, R\u00f6ther J, Goto S, Liau CS, Wilson PW, Salette G, Smith SC, Steg PG, Registry Investigators REACH (2011) Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Mayo Clin Proc 86:960\u2013967","journal-title":"Mayo Clin Proc"},{"key":"2240_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4244\/EIJY14M06_09","volume":"11","author":"Y Onuma","year":"2015","unstructured":"Onuma Y, Kimura T, R\u00e4ber L, Magro M, Girasis C, van Domburg R, Windecker S, Mitsudo K, Serruys PW, Bern-Rotterdam and j-Cypher registries (2015) Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries. EuroIntervention 11:533\u2013540","journal-title":"EuroIntervention"},{"key":"2240_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, J\u00fcni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two institutional cohort study. Lancet 369:667\u2013678","journal-title":"Lancet"},{"key":"2240_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1055\/s-0038-1676545","volume":"119","author":"J Kang","year":"2019","unstructured":"Kang J, Park KW, Palmerini T, Stone GW, Lee MS, Colombo A, Chieffo A, Feres F, Abizaid A, Bhatt DL, Valgimigli M, Hong MK, Jang Y, Gilard M, Morice MC, Park DW, Park SJ, Jeong YH, Park J, Koo BK, Kim HS (2019) Racial differences in ischaemia\/bleeding risk trade-off during anti-platelet therapy: individual patient level landmark meta-analysis from seven RCTs. Thromb Haemost 119:149\u2013162","journal-title":"Thromb Haemost"},{"key":"2240_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jcin.2008.06.011","volume":"1","author":"DW Park","year":"2008","unstructured":"Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ (2008) Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting vs. bare-metal stents. JACC Cardiovasc Interv 1:494\u2013503","journal-title":"JACC Cardiovasc Interv"},{"key":"2240_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11886-014-0485-4","volume":"16","author":"YH Jeong","year":"2014","unstructured":"Jeong YH (2014) \"East asian paradox\": challenge for the current antiplatelet strategy of \"one-guideline-fits-all races\" in acute coronary syndrome. Curr Cardiol Rep 16:485","journal-title":"Curr Cardiol Rep"},{"key":"2240_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2174\/1570161116666180117103238","volume":"16","author":"JS Bae","year":"2018","unstructured":"Bae JS, Ahn JH, Tantry US, Gurbel PA, Jeong YH (2018) Should antithrombotic treatment strategies in East Asians differ from Caucasians? Curr Vasc Pharmacol 16:459\u2013476","journal-title":"Curr Vasc Pharmacol"},{"key":"2240_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","volume":"11","author":"GN Levine","year":"2014","unstructured":"Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SC Jr (2014) Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol 11:597\u2013606","journal-title":"Nat Rev Cardiol"},{"key":"2240_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.scib.2018.12.020","volume":"64","author":"Y Huo","year":"2019","unstructured":"Huo Y, Jeong YH, Gong Y, Wang D, He B, Chen J, Fu G, Chen Y, Li J, Li Y, Goto S, Tantry US, Gurbel PA, Ahn JH, Kim HS, Jeong MH, Han Y, Smith SC, Ge J (2019) 2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Sci Bull 64:166\u2013179","journal-title":"Sci Bull"},{"key":"2240_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.gheart.2014.11.004","volume":"10","author":"CM Gijsberts","year":"2015","unstructured":"Gijsberts CM, den Ruijter HM, Asselbergs FW, Chan MY, de Kleijn DP, Hoefer IE (2015) Biomarkers of coronary artery disease differ between Asians and Caucasians in the general population. Glob Heart 10:301\u2013311.e11","journal-title":"Glob Heart"},{"key":"2240_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2010.07.002","volume":"152","author":"DA Gorog","year":"2011","unstructured":"Gorog DA, Yamamoto J, Saraf S, Ishii H, Ijiri Y, Ikarugi H, Wellsted DM, Mori M, Yamori Y (2011) First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: possible relationship to the \"Japanese paradox\". Int J Cardiol 152:43\u201348","journal-title":"Int J Cardiol"},{"key":"2240_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1373\/clinchem.2007.098996","volume":"54","author":"A Kelley-Hedgepeth","year":"2008","unstructured":"Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld B, Pasternak RC, Chae CU, Investigators SWAN (2008) Ethnic differences in C-reactive protein concentrations. Clin Chem 54:1027\u20131037","journal-title":"Clin Chem"},{"key":"2240_CR14","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1111\/j.1538-7836.2006.02237.x","volume":"4","author":"PL Lutsey","year":"2006","unstructured":"Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR (2006) Plasma hemostatic factors and endothelial markers in four racial\/ethnic groups: the MESA study. J Thromb Haemost 4:2629\u20132635","journal-title":"J Thromb Haemost"},{"key":"2240_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1160\/TH13-08-0643","volume":"111","author":"YH Jeong","year":"2014","unstructured":"Jeong YH, Bliden KP, Shuldiner AR, Tantry US, Gurbel PA (2014) Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes. Thromb Haemost 111:713\u2013724","journal-title":"Thromb Haemost"},{"key":"2240_CR16","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","volume":"46","author":"PA Gurbel","year":"2005","unstructured":"Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US (2005) Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 46:1820\u20131826","journal-title":"J Am Coll Cardiol"},{"key":"2240_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","volume":"5","author":"E Mahla","year":"2012","unstructured":"Mahla E, Suarez TA, Bliden KP, Rehak P, Metzler H, Sequeira AJ, Cho P, Sell J, Fan J, Antonino MJ, Tantry US, Gurbel PA (2012) Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 5:261\u2013269","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"2240_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11239-019-01813-0","volume":"47","author":"KP Bliden","year":"2019","unstructured":"Bliden KP, Raviv G, Tantry US, Chaudhary R, Cochran JW, Navarese EP, Brannan T, Vyas A, Gurbel PA (2019) \"Blueprinting\" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke. J Thromb Thrombolysis 47(2):192\u2013199","journal-title":"J Thromb Thrombolysis"},{"key":"2240_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02103-w","author":"JS Bae","year":"2020","unstructured":"Bae JS, Ahn JH, Jang JY, Cho SY, Kang MG, Kim KH, Park HW, Koh JS, Park Y, Hwang SJ, Kwak CH, Hwang JY, Tantry US, Gurbel PA, Jeong YH (2020) The Impact of platelet-fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease. J Thromb Thrombolysis. https:\/\/doi.org\/10.1007\/s11239-020-02103-w","journal-title":"J Thromb Thrombolysis"},{"key":"2240_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2017.11.018","volume":"268","author":"KP Bliden","year":"2018","unstructured":"Bliden KP, Chaudhary R, Navarese EP, Sharma T, Kaza H, Tantry US, Gurbel PA (2018) Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: the MAGMA-ischemia score. Atherosclerosis 268:55\u201362","journal-title":"Atherosclerosis"},{"key":"2240_CR21","doi-asserted-by":"publisher","first-page":"e001167","DOI":"10.1161\/JAHA.114.001167","volume":"3","author":"EI Lev","year":"2014","unstructured":"Lev EI, Bliden KP, Jeong YH, Pandya S, Kang K, Franzese C, Tantry US, Gurbel PA (2014) Influence of race and sex on thrombogenicity in a large cohort of coronary artery disease patients. J Am Heart Assoc 3:e001167","journal-title":"J Am Heart Assoc"},{"key":"2240_CR22","doi-asserted-by":"crossref","unstructured":"Chen Y, Freedman ND, Albert PS, Huxley RR, Shiels MS, Withrow DR, Spillane S, Powell-Wiley TM, Berrington de Gonz\u00e1lez A (2020) Association of cardiovascular disease with premature mortality in the United States. JAMA Cardiol [Epub ahead of print]","DOI":"10.1001\/jamacardio.2019.3891"},{"key":"2240_CR23","doi-asserted-by":"crossref","unstructured":"Pu J, Hastings KG, Boothroyd D, Jose PO, Chung S, Shah JB, Cullen MR, Palaniappan LP, Rehkopf DH (2017) Geographic variations in cardiovascular disease mortality among Asian American subgroups, 2003\u20132011. J Am Heart Assoc 6(7).","DOI":"10.1161\/JAHA.117.005597"},{"key":"2240_CR24","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.jacc.2011.08.057","volume":"58","author":"DW Park","year":"2011","unstructured":"Park DW, Lee SW, Yun SC, Song HG, Ahn JM, Lee JY, Kim WJ, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ (2011) A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. J Am Coll Cardiol 58:2630\u20132639","journal-title":"J Am Coll Cardiol"},{"key":"2240_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","volume":"367","author":"Z Ye","year":"2006","unstructured":"Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367:651\u2013658","journal-title":"Lancet"},{"key":"2240_CR26","doi-asserted-by":"publisher","first-page":"30506","DOI":"10.1038\/srep30506","volume":"6","author":"Y Peng","year":"2016","unstructured":"Peng Y, Wang H, Li YM, Huang BT, Huang FY, Xia TL, Chai H, Wang PJ, Liu W, Zhang C, Chen M, Huang DJ (2016) Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease. Sci Rep 6:30506","journal-title":"Sci Rep"},{"issue":"Suppl 4","key":"2240_CR27","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","volume":"123","author":"RH White","year":"2009","unstructured":"White RH, Keenan CR (2009) Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 123(Suppl 4):S11\u201317","journal-title":"Thromb Res"},{"key":"2240_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1055\/s-0030-1265286","volume":"36","author":"J Wegner","year":"2010","unstructured":"Wegner J, Popovsky MA (2010) Clinical utility of thromboelastography: one size does not fit all. Semin Thromb Hemost 36:699\u2013706","journal-title":"Semin Thromb Hemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02240-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:40:18Z","timestamp":1630024818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02240-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2240"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02240-2","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"27 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Jeong has received honoraria for lectures from AstraZeneca, Sanofi-Aventis, Daiichi Sankyo\/Lilly, Haemonetics, Otsuka, Han-mi Pharmaceuticals and Yuhan Pharmaceuticals; and research grants or support from AstraZeneca, Korean Society of Interventional Cardiology, Han-mi Pharmaceuticals, Yuhan Pharmaceuticals, Otsuka and Haemonetics. Dr. Gurbel reports receiving grants from Bayer, Medicure, Instrumentation labs, Haemonetics, Amgen, Idorsia, Hikari Dx, Inc, and Janssen; receiving honoraria and payment for lectures, consultation from Bayer, UptoDate, Otitopic, Inc., Medicure, and Janssen. The other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}